Personalized Diabetes Education with CGM for Type 2 Diabetes

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
72 (estimated)
Sponsor
University of Minnesota · Other
Who this trial is looking for

This trial is looking for adults with type 2 diabetes. Participants will receive personalized nutrition advice based on their continuous glucose monitor readings.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I have been diagnosed with type 2 diabetes
  • My HbA1c level is between 6.8 and 8.5%

You may not be able to join if

  • I have type 1 diabetes
  • I take insulin or certain diabetes medications
  • I use medications that affect blood sugar control
  • My BMI is less than 25
  • I have lost more than 5 pounds in the last 3 months
  • My kidney function is below a certain level
  • I am pregnant or planning to become pregnant
  • I have anemia that affects my HbA1c measurement

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * at least 18 years of age * previous diagnosis of T2DM * HbA1c of 6.8-8.5% Exclusion Criteria: * type 1 diabetes mellitus * treatment with insulin, sulfonylurea, or meglitinide * use of nondiabetic medications that affect blood glucose control (such as corticosteroids) * BMI …
Contacts

Anne Bantle

612-625-8673

bant0015@umn.edu

CONTACT